NM_153758.5:c.-149+2474T>A
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_153758.5(IL19):c.-149+2474T>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_153758.5 intron
Scores
Clinical Significance
Conservation
Publications
- IL10-related early-onset inflammatory bowel diseaseInheritance: AR Classification: SUPPORTIVE, LIMITED Submitted by: Orphanet, Ambry Genetics
- systemic lupus erythematosusInheritance: Unknown Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_153758.5. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| IL19 | NM_153758.5 | MANE Select | c.-149+2474T>A | intron | N/A | NP_715639.2 | |||
| IL19 | NM_001393490.1 | c.-149+2722T>A | intron | N/A | NP_001380419.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| IL19 | ENST00000659997.3 | MANE Select | c.-149+2474T>A | intron | N/A | ENSP00000499459.2 | |||
| IL19 | ENST00000656872.2 | c.-149+2722T>A | intron | N/A | ENSP00000499487.2 | ||||
| IL10 | ENST00000659065.2 | c.-15+128A>T | intron | N/A | ENSP00000499588.1 |
Frequencies
GnomAD3 genomes Cov.: 29
GnomAD4 genome Cov.: 29
ClinVar
Not reported inComputational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at